Back to news
REGULATORYThe Marijuana Herald

FDA tests first regulatory exception for a drug ingredient sold as a supplement

FDA proposed using its statutory authority for the first time to let NAC, a previously approved drug ingredient, be marketed as a dietary supplement. The proposal does not authorize CBD, but it demonstrates a rulemaking mechanism that Oklahoma CBD manufacturers should watch while federal supplement restrictions remain unresolved.

Share this update

FacebookXLinkedInEmail

#national#hemp#cbd#compliance#fda

Read the original source

Leafy summaries provide industry context. Confirm details with The Marijuana Herald.

Open source

Continue reading

Related industry updates